Comments on: Big Pharma’s Loss May Be Little Pharma’s Gain http://www.pharmalot.com/2008/11/big-pharmas-loss-may-be-little-pharmas-gain/ News, Comment and Conversation Fri, 10 Feb 2012 20:32:59 +0000 http://wordpress.org/?v=2.6.2 By: Leslie http://www.pharmalot.com/2008/11/big-pharmas-loss-may-be-little-pharmas-gain/#comment-624876 Leslie Sun, 08 May 2011 19:44:54 +0000 http://www.pharmalot.com/?p=17350#comment-624876 Great post, truly! <a href="http://aweightlosstips.wordpress.com" rel="nofollow">http://aweightlosstips.wordpress.com</a> Great post, truly!

http://aweightlosstips.wordpress.com

]]> By: Dunnoh http://www.pharmalot.com/2008/11/big-pharmas-loss-may-be-little-pharmas-gain/#comment-380685 Dunnoh Fri, 07 Nov 2008 05:18:26 +0000 http://www.pharmalot.com/?p=17350#comment-380685 Truth is that the whole industry is in the crosshairs and its naive to think small is exempt, in fact, risk is exponential since 90% are one-drug-ponies and if they fail in the clinic,,,oh well! see ya! Companies with cash, revenues and hard assets still beat ones with molecules and targets.... Truth is that the whole industry is in the crosshairs and its naive to think small is exempt, in fact, risk is exponential since 90% are one-drug-ponies and if they fail in the clinic,,,oh well! see ya!

Companies with cash, revenues and hard assets still beat ones with molecules and targets….

]]> By: CMC guy http://www.pharmalot.com/2008/11/big-pharmas-loss-may-be-little-pharmas-gain/#comment-380605 CMC guy Thu, 06 Nov 2008 16:09:24 +0000 http://www.pharmalot.com/?p=17350#comment-380605 Basically Stock is saying he can get experienced people for cut rate prices and in terms of his stock options statement it is meaningless if company does not survive long enough or can not execute an IPO (which is current market situation). Working at smaller companies does offer some benefits but there are downsides too and in general the lack having key people at the right time further reduces to chance to develop a successful drug which even Big Pharma struggles with the challenges. Basically Stock is saying he can get experienced people for cut rate prices and in terms of his stock options statement it is meaningless if company does not survive long enough or can not execute an IPO (which is current market situation).

Working at smaller companies does offer some benefits but there are downsides too and in general the lack having key people at the right time further reduces to chance to develop a successful drug which even Big Pharma struggles with the challenges.

]]>